Reported Earlier, Nutex Health Preliminary Q2 Revenue $244M Up From $76.1M YoY, Adjusted EBITDA $71.6M Up From $6.8M YoY

Author: Benzinga Newsdesk | August 21, 2025 03:31am

Financial highlights for the three months ended June 30, 2025:

• Total revenue was $244.0 million for the three months ended June 30, 2025 as compared to total revenue of $76.1 million for the same period in 2024, an increase of 220.7%. Revenue from mature hospitals, which are hospitals opened prior to December 31, 2021, increased by 203.2% in 2025 compared to 2024.
• Gross profit was $124.8 million, or 51.1% of total revenue, for the three months ended June 30, 2025 as compared to gross profit of $22.6 million, or 29.7% of total revenue, for the same period in 2024.
• Total visits at the Hospital Division were 45,573 for the three months ended June 30, 2025, as compared to 41,208 for the same period in 2024, an increase of 4,365 or 10.6%. Visits at mature hospitals increased by 0.6% in the three months ended June 30, 2025 as compared to the same period in 2024.
• For the three months ended June 30, 2025, the Company collected $175 million in cash, the highest collection amount for any quarter.
• Adjusted EBITDA was $71.6 million for the three months ended June 30, 2025 as compared to $6.8 million for the same period in 2024.
• Operating cash flow was $27.1 million for the three months ended June 30, 2025 as compared to $13.3 million for the same period in 2024.

Posted In: NUTX